Nehal Mohamed

1.6k total citations
16 papers, 439 citations indexed

About

Nehal Mohamed is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nehal Mohamed has authored 16 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nehal Mohamed's work include Biochemical and Structural Characterization (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Renal cell carcinoma treatment (2 papers). Nehal Mohamed is often cited by papers focused on Biochemical and Structural Characterization (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Renal cell carcinoma treatment (2 papers). Nehal Mohamed collaborates with scholars based in United States, United Kingdom and Egypt. Nehal Mohamed's co-authors include Julia Ross, George L. Spitalny, Leslie S. Casey, Juan Li, Flora F. Barsoum, Kamilia M. Amin, Steven Pincus, Fadi M. Awadallah, Linda L. Nardone and Michael C. Babin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Infection and Immunity.

In The Last Decade

Nehal Mohamed

16 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nehal Mohamed United States 11 264 98 64 55 47 16 439
Susanne Kubetzko Switzerland 6 297 1.1× 88 0.9× 59 0.9× 90 1.6× 43 0.9× 8 535
Djenet Bousbaine United States 11 272 1.0× 76 0.8× 114 1.8× 148 2.7× 66 1.4× 15 589
Amy Jacobs United States 14 292 1.1× 213 2.2× 42 0.7× 155 2.8× 22 0.5× 29 625
Wah Y. Wong Canada 12 379 1.4× 34 0.3× 127 2.0× 44 0.8× 20 0.4× 22 517
Robert C. Unfer United States 14 158 0.6× 138 1.4× 83 1.3× 100 1.8× 14 0.3× 18 457
Michael Weichel Switzerland 15 263 1.0× 95 1.0× 29 0.5× 105 1.9× 37 0.8× 30 783
Peter Sebbel Switzerland 9 529 2.0× 72 0.7× 149 2.3× 197 3.6× 30 0.6× 10 1.0k
Kévin Canis United Kingdom 12 437 1.7× 61 0.6× 44 0.7× 189 3.4× 31 0.7× 14 783
Pauline Malinge Switzerland 13 397 1.5× 119 1.2× 58 0.9× 277 5.0× 58 1.2× 24 788
Richard Chubet United States 7 299 1.1× 151 1.5× 51 0.8× 78 1.4× 47 1.0× 8 542

Countries citing papers authored by Nehal Mohamed

Since Specialization
Citations

This map shows the geographic impact of Nehal Mohamed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nehal Mohamed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nehal Mohamed more than expected).

Fields of papers citing papers by Nehal Mohamed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nehal Mohamed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nehal Mohamed. The network helps show where Nehal Mohamed may publish in the future.

Co-authorship network of co-authors of Nehal Mohamed

This figure shows the co-authorship network connecting the top 25 collaborators of Nehal Mohamed. A scholar is included among the top collaborators of Nehal Mohamed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nehal Mohamed. Nehal Mohamed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Choueiri, Toni K., Laurence Albigès, Thomas Powles, et al.. (2020). 342 A phase 3 study (COSMIC-313) of cabozantinib in combination with nivolumab and ipilimumab in patients with previously untreated advanced renal cell carcinoma of intermediate or poor risk. Regular and Young Investigator Award Abstracts. A209.1–A209. 1 indexed citations
3.
Spencer, Kristen, Giridharan Ramsingh, Nehal Mohamed, Sumanta K. Pal, & Lorenza Rimassa. (2019). Phase Ib trial of cabozantinib (C) in combination with atezolizumab (A) in patients (pts) with advanced hepatocellular carcinoma (HCC), gastric or gastroesophageal junction cancer (GC/GEJC), or colorectal cancer (CRC).. Journal of Clinical Oncology. 37(4_suppl). TPS478–TPS478. 5 indexed citations
4.
Hassib, Sonia T., et al.. (2018). Development and Validation of a Stability-Indicating Chromatographic Method for the Determination of Indacaterol Maleate with Glycopyrronium Bromide in Mixture. Current Pharmaceutical Analysis. 15(7). 694–702. 5 indexed citations
5.
Amin, Kamilia M., Flora F. Barsoum, Fadi M. Awadallah, & Nehal Mohamed. (2016). Identification of new potent phthalazine derivatives with VEGFR-2 and EGFR kinase inhibitory activity. European Journal of Medicinal Chemistry. 123. 191–201. 46 indexed citations
7.
Wu, Peng, Xin Zhang, Nehal Mohamed, et al.. (2005). A DeImmunized chimeric anti-C3b/iC3b monoclonal antibody enhances rituximab-mediated killing in NHL and CLL cells via complement activation. Cancer Immunology Immunotherapy. 54(12). 1172–1179. 15 indexed citations
8.
Mohamed, Nehal, Steven J.M. Jones, Leslie S. Casey, Steven Pincus, & George L. Spitalny. (2005). Heteropolymers: a novel technology against blood-borne infections.. PubMed. 7(2). 144–50. 10 indexed citations
9.
Pincus, S, Ionita Ghiran, A Nicholson-Weller, et al.. (2005). A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1). Clinical & Experimental Immunology. 140(2). 230–240. 28 indexed citations
10.
Mohamed, Nehal, Juan Li, Steven M. Jones, et al.. (2005). A High-Affinity Monoclonal Antibody to Anthrax Protective Antigen Passively Protects Rabbits before and after Aerosolized Bacillus anthracis Spore Challenge. Infection and Immunity. 73(2). 795–802. 95 indexed citations
11.
Mohamed, Nehal, Juan Li, Cláudia S. Ferreira, et al.. (2004). Enhancement of Anthrax Lethal Toxin Cytotoxicity: a Subset of Monoclonal Antibodies against Protective Antigen Increases Lethal Toxin-Mediated Killing of Murine Macrophages. Infection and Immunity. 72(6). 3276–3283. 57 indexed citations
12.
Mohamed, Nehal, Livia Visai, Pietro Speziale, & Julia Ross. (2000). Quantification of Staphylococcus aureus cell surface adhesins using flow cytometry. Microbial Pathogenesis. 29(6). 357–361. 17 indexed citations
13.
Mohamed, Nehal, et al.. (2000). Novel experimental study of receptor-mediated bacterial adhesion under the influence of fluid shear. Biotechnology and Bioengineering. 68(6). 628–636. 59 indexed citations
14.
Mohamed, Nehal, et al.. (2000). Novel experimental study of receptor‐mediated bacterial adhesion under the influence of fluid shear. Biotechnology and Bioengineering. 68(6). 628–636. 2 indexed citations
15.
Mohamed, Nehal, et al.. (1999). Inhibition ofStaphylococcus aureusAdherence to Collagen under Dynamic Conditions. Infection and Immunity. 67(2). 589–594. 45 indexed citations
16.
Mohamed, Nehal, et al.. (1999). Functional Analysis of the Staphylococcus aureus Collagen Adhesin B Domain. Infection and Immunity. 67(8). 3952–3959. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026